Agilent Technologies (NYSE:A) Given “Outperform” Rating at Sanford C. Bernstein

Agilent Technologies (NYSE:A)‘s stock had its “outperform” rating restated by equities researchers at Sanford C. Bernstein in a research report issued on Friday,Benzinga reports. They presently have a $155.00 price target on the medical research company’s stock. Sanford C. Bernstein’s price objective would suggest a potential upside of 14.20% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. HSBC cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Barclays raised their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Morgan Stanley lowered their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $160.88.

Agilent Technologies Price Performance

Shares of A opened at $135.73 on Friday. The firm has a market cap of $38.33 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 2.34 and a beta of 1.26. Agilent Technologies has a 52-week low of $108.35 and a 52-week high of $160.27. The business’s 50 day moving average price is $122.53 and its two-hundred day moving average price is $126.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the previous year, the business posted $1.31 EPS. Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts anticipate that Agilent Technologies will post 6 EPS for the current year.

Institutional Trading of Agilent Technologies

Institutional investors and hedge funds have recently made changes to their positions in the company. Sapient Capital LLC grew its position in Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after purchasing an additional 85 shares in the last quarter. Optiver Holding B.V. purchased a new position in shares of Agilent Technologies in the 1st quarter worth approximately $496,000. Ritter Alpha LP bought a new position in shares of Agilent Technologies in the first quarter valued at approximately $203,000. Summitry LLC increased its position in shares of Agilent Technologies by 8.1% during the first quarter. Summitry LLC now owns 673,954 shares of the medical research company’s stock valued at $76,817,000 after acquiring an additional 50,441 shares during the last quarter. Finally, Segall Bryant & Hamill LLC bought a new stake in Agilent Technologies during the first quarter worth $9,041,000.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.